- Body Systems
- Health Care
- Threats to Health
- Healthy Living
- medications
- pharmacokinetics
- dosage calculations
- routes of administration
- e-CPS
- Dal Pharm Drug Info
- RxFiles
Section Links
Tenecteplase
fibrinolytic given immediately following an acute myocardial infarction
- uses
- mechanism
- dose and half-life
- adverse drug reactions
- counter-indications and drug interactions
- metabolism and excretion
- dependency
Uses
- useful within 6 hours post-MI, or maybe 12;
- given within 2 hours is much better
Mechanism
- cells
- proteins
Dose and Half Life
Adverse Drug Reactions
short term
long term
Counter-Indications and Drug Interactions
- dangerous in cases of potential bleeds
Metabolism and Excretion
Dependency
This information is for training in careers with many inherent risks. Do not base any decision or action on this site's contents, either for yourself or someone else, without first consulting with a health care professional. Sharing In Health cannot be held responsible for adverse events of any kind.
Please forgive and contact david . lapierre @ dal . ca if you have found any errors of commission or omission as this site develops.